# Earnouts, Contingent Consideration, and Deal Terms
In 2016, Bayer agreed to buy Monsanto for $128 per share in all cash—no earnout, no contingent value right, no clever bridge. Bayer simply paid the seller's number. By 2020 it had absorbed over $10 billion in Roundup litigation settlements and its market cap had fallen below what it paid for the target alone. The lesson isn't "diligence harder." It's that Bayer accepted 100% of an unknowable future risk at the moment of signing because its deal structure gave it no other place to put it. A different set of terms—an escrow tied to litigation outcomes, a reps-and-warranties framework that survived closing, a portion of consideration contingent on realized liabilities—would have left billions of dollars of that risk with the party who actually created and understood it.
This is the core discipline of deal structuring: you are not negotiating a price, you are negotiating a distribution of outcomes. Price is a single number that assumes you know the future. Structure is the machinery that decides who pays when the future disagrees with the model. The CFO who treats these as separate skills overpays on the deals that look cheap and walks away from the deals that were actually winnable.
When a buyer models a target at $180 million and the seller insists on $240 million, the amateur read is that someone is wrong. The sophisticated read is that the two parties hold different probability distributions over the same future—and the $60 million gap is a *quantification of their disagreement.*
Almost always, the disagreement clusters around a small number of forward assumptions: revenue growth after the founder leaves, retention of a concentrated customer, the outcome of a pending regulatory approval, or the realizability of a pipeline. The seller, who lives inside the business, believes the converts. The buyer, who has seen a hundred pipelines, applies a haircut. Neither can prove their case at signing.
The structural insight is this: do not pay today for a belief you cannot verify today. Instead, isolate the specific assumption driving the gap and build a contingent instrument that pays the seller *if and only if* their belief turns out to be correct. You have converted an argument about valuation into an agreement about facts—facts that time will settle.
This reframes the CFO's job. Your task is not to win the price argument. It is to (1) decompose the gap into its underlying risk drivers, (2) assign each driver to the party best positioned to bear or control it, and (3) select the instrument that enforces that assignment. Risk allocation theory is unambiguous here: a risk should be borne by whoever can most cheaply influence or absorb it. The seller controls near-term operating performance; the buyer controls post-close integration and capital. Structure should follow that logic, not the balance of negotiating egos.
Each deal term is a risk-transfer device with a distinct payoff profile. Choosing among them is the substance of structuring.
An earnout defers a portion of consideration and ties it to post-close metrics—revenue, EBITDAEBITDAEBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) measures a company's operating profitability before financing and accounting decisions, used to compare core performance across firms.View full definition →, unit volume, a product milestone. It is the natural bridge for a growth-driven valuation gap, because it lets the seller monetize their optimism only if the business delivers it.
The trap is that earnouts create misaligned incentives during the earnout period and manufacture litigation. The buyer now controls the business but the seller's payout depends on it. Every integration decision—reallocating a salesforce, changing pricing, deferring a launch to the next fiscal year—can be read by the seller as sabotage designed to suppress the earnout. This is not hypothetical; earnout disputes are among the most common sources of post-close M&A litigation, and Delaware courts have repeatedly wrestled with the implied covenant of good faith in operating the target during the measurement window.
The CFO's practical rules:
Where an earnout funds seller upside, an escrow protects buyer downside. A portion of purchase price—commonly 10–15%—is held by a third party for 12–24 months to satisfy claims for breached representations, undisclosed liabilities, or working-capital adjustments. The escrow is a pre-funded recourse mechanism: it converts the buyer's post-close claim from a lawsuit into a simple release-of-funds negotiation. The party holding the cash holds the leverage.
The distinction to internalize: an escrow addresses risks that *already exist but are not yet measured* (a tax exposure, a customer that may churn). An earnout addresses value that *does not yet exist and may never*. Confusing the two produces structures that protect the wrong party against the wrong risk.
Representations are the seller's factual assertions about the business; warranties promise those facts are true; indemnification is the remedy when they aren't. Together they form the contractual risk allocation grid, governed by three levers the CFO must negotiate deliberately:
Over the last decade, R&W insurance has moved from exotic to default in the middle market. For a premium of roughly 2–4% of coverage, an insurer assumes the indemnification obligation, allowing a clean exit for sellers (no large escrow, no lingering claw-back) while giving buyers a solvent, deep-pocketed counterparty instead of chasing a dispersed selling group. For the CFO, R&W insurance is a tool to *unlock a deal where the seller demands liquidity* and to convert an uncertain, relationship-damaging clawback into a priced, transferable cost. The judgment call: the insurer will exclude known issues and matters surfaced in diligence, so it never substitutes for structure on the risks you actually identified—only on the unknown-unknowns.
Return to the $180M-versus-$240M gap. Decompose it and the disagreement resolves into three drivers:
1. $40M hinges on whether the target's two largest customers renew (seller confident, buyer skeptical).
2. $15M reflects a pending IP dispute the seller insists is frivolous.
3. $5M is genuine negotiating spread.
A structured bridge might look like this. Pay $185M at closing—above the buyer's base case, splitting the pure spread. Place $40M into a two-year revenue earnout conditioned on retention of the named accounts, with explicit covenants requiring the buyer to maintain existing service levels and pricing. Hold $15M in escrow released only upon resolution of the IP matter, with any adverse judgment funded first from escrow. Layer R&W insurance across the general reps so the seller walks with clean proceeds on everything else.
The seller can now reachreachThe number of unique people exposed to your message in a given period. Unlike impressions, reach counts each person once, no matter how often they see it.View full definition → $240M—but only by proving the business is worth it. The buyer caps its true exposure at $185M plus outcomes it verified were real. Neither party paid for a belief. The gap didn't close; it got *distributed to the parties who each thought they were right,* and time will pay whoever was.
Knowledge check
1. According to the lesson, what is the fundamental reframe that distinguishes sophisticated deal structuring from amateur negotiation?
2. The Bayer–Monsanto example is used primarily to illustrate which structural principle?
3. How does the lesson interpret a large valuation gap between a buyer's model and a seller's asking price?
4. Select ALL correct answers about the deal structuring tools mentioned as ways to reallocate future risk to the party who created or understands it.
Select all the correct answers.
5. Select ALL correct answers describing why a valuation gap typically arises, per the lesson.
Select all the correct answers.
Structure is not free, and the CFO who reaches for it reflexively creates a different set of problems.
Complexity is a liability. Every contingent term is a future measurement obligation, a potential dispute, and a line item your controllers must track for years. A three-tranche earnout with quarterly EBITDAEBITDAEBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) measures a company's operating profitability before financing and accounting decisions, used to compare core performance across firms.View full definition → measurement and adjustment clauses is a full-time job for someone in your organization. The accounting alone—fair-valuing and remeasuring contingent consideration under ASC 805 each reporting period, with the changes hitting earnings—can inject volatility into your P&L that analysts will question and that has nothing to do with operating performance.
Structure signals distrust. In competitive auctions, a seller with multiple bidders will discount a heavily contingent offer relative to clean cash, even at a higher headline number, because certainty has value. A private-equity buyer offering $200M all-cash will often beat a strategic offering $230M with half in earnout. The CFO must price the *certainty premium* the market demands and recognize that in a hot process, elegant structure loses to simple cash.
Earnouts govern the integration you actually want. The most under-appreciated cost is strategic. An earnout tied to the target's standalone revenue can *forbid you from doing the integration that justified the deal*—cross-selling, consolidating salesforces, killing overlapping products—because each move risks depressing the standalone metric and triggering a dispute. You bought the company to combine it and then signed a contract that penalizes combination. Resolve this tension at the negotiating table, not in year two.
The discipline, then, is to reachreachThe number of unique people exposed to your message in a given period. Unlike impressions, reach counts each person once, no matter how often they see it.View full definition → for structure precisely where the valuation gap is (a) large, (b) concentrated in one or two verifiable drivers, and (c) resolvable within a short, measurable window. Where the gap is diffuse, where the metric is manipulable, or where integration must move fast, take the pain in the price and buy the business clean.